CAY10763 |
A dual inhibitor of IDO1 and STAT3 activation (IC50 = 46 nM); binds to STA… |
500 µg |
30593-500 |
More Info
|
CAY10766 |
An antiviral compound; inhibits entry of influenza virus-like particles ps… |
1 mg |
30604-1 |
More Info
|
CAY10766 |
An antiviral compound; inhibits entry of influenza virus-like particles ps… |
10 mg |
30604-10 |
More Info
|
CAY10766 |
An antiviral compound; inhibits entry of influenza virus-like particles ps… |
5 mg |
30604-5 |
More Info
|
CAY10767 |
A PPARα agonist (EC50 = 37 nM in a reporter assay); >2,700-fold sele… |
1 mg |
30605-1 |
More Info
|
CAY10767 |
A PPARα agonist (EC50 = 37 nM in a reporter assay); >2,700-fold sele… |
5 mg |
30605-5 |
More Info
|
CAY10767 |
A PPARα agonist (EC50 = 37 nM in a reporter assay); >2,700-fold sele… |
500 µg |
30605-500 |
More Info
|
CAY10770 |
An inhibitor of CYP4Z1 (IC50 = 5.9 µM); selective for CYP4Z1 over CY… |
1 mg |
31216-1 |
More Info
|
CAY10770 |
An inhibitor of CYP4Z1 (IC50 = 5.9 µM); selective for CYP4Z1 over CY… |
250 µg |
31216-250 |
More Info
|
CAY10770 |
An inhibitor of CYP4Z1 (IC50 = 5.9 µM); selective for CYP4Z1 over CY… |
500 µg |
31216-500 |
More Info
|
CAY10771 |
A dual agonist of FXR and PPARδ; activates FXR and PPARδ in re… |
1 mg |
31758-1 |
More Info
|
CAY10771 |
A dual agonist of FXR and PPARδ; activates FXR and PPARδ in re… |
10 mg |
31758-10 |
More Info
|
CAY10771 |
A dual agonist of FXR and PPARδ; activates FXR and PPARδ in re… |
5 mg |
31758-5 |
More Info
|
CAY10773 |
A derivative of sorafenib; selectively inhibits proliferation of BEL-7402,… |
1 mg |
31806-1 |
More Info
|
CAY10773 |
A derivative of sorafenib; selectively inhibits proliferation of BEL-7402,… |
10 mg |
31806-10 |
More Info
|
CAY10773 |
A derivative of sorafenib; selectively inhibits proliferation of BEL-7402,… |
5 mg |
31806-5 |
More Info
|
CAY10774 |
A PD-1 / PD-L1 interaction inhibitor (IC50 = 15 nM in a HTRF assay); incre… |
1 mg |
32569-1 |
More Info
|
CAY10774 |
A PD-1 / PD-L1 interaction inhibitor (IC50 = 15 nM in a HTRF assay); incre… |
10 mg |
32569-10 |
More Info
|
CAY10774 |
A PD-1 / PD-L1 interaction inhibitor (IC50 = 15 nM in a HTRF assay); incre… |
5 mg |
32569-5 |
More Info
|
CAY10774 |
A PD-1 / PD-L1 interaction inhibitor (IC50 = 15 nM in a HTRF assay); incre… |
500 µg |
32569-500 |
More Info
|
CAY10777 |
An antiproliferative agent; inhibits the proliferation of HepG2 cells in v… |
1 mg |
32712-1 |
More Info
|
CAY10777 |
An antiproliferative agent; inhibits the proliferation of HepG2 cells in v… |
10 mg |
32712-10 |
More Info
|
CAY10777 |
An antiproliferative agent; inhibits the proliferation of HepG2 cells in v… |
5 mg |
32712-5 |
More Info
|
CAY10781 |
An NRP-1 / VEGF-A interaction inhibitor; inhibits the interaction by 43% a… |
10 mg |
33778-10 |
More Info
|
CAY10781 |
An NRP-1 / VEGF-A interaction inhibitor; inhibits the interaction by 43% a… |
100 mg |
33778-100 |
More Info
|
CAY10781 |
An NRP-1 / VEGF-A interaction inhibitor; inhibits the interaction by 43% a… |
250 mg |
33778-250 |
More Info
|
CAY10781 |
An NRP-1 / VEGF-A interaction inhibitor; inhibits the interaction by 43% a… |
50 mg |
33778-50 |
More Info
|
CAY10784 |
A STAT3 inhibitor (IC50 = 0.74 µM in a reporter assay) and a derivat… |
1 mg |
34020-1 |
More Info
|
CAY10784 |
A STAT3 inhibitor (IC50 = 0.74 µM in a reporter assay) and a derivat… |
10 mg |
34020-10 |
More Info
|
CAY10784 |
A STAT3 inhibitor (IC50 = 0.74 µM in a reporter assay) and a derivat… |
25 mg |
34020-25 |
More Info
|
CAY10784 |
A STAT3 inhibitor (IC50 = 0.74 µM in a reporter assay) and a derivat… |
5 mg |
34020-5 |
More Info
|
CAY10788 |
A CysLT1 receptor antagonist (IC50 = 3.9 µM) |
1 mg |
35324-1 |
More Info
|
CAY10788 |
A CysLT1 receptor antagonist (IC50 = 3.9 µM) |
10 mg |
35324-10 |
More Info
|
CAY10788 |
A CysLT1 receptor antagonist (IC50 = 3.9 µM) |
25 mg |
35324-25 |
More Info
|
CAY10788 |
A CysLT1 receptor antagonist (IC50 = 3.9 µM) |
5 mg |
35324-5 |
More Info
|
CAY10789 |
A CysLT1 receptor antagonist (IC50 = 2.1 µM) |
1 mg |
35325-1 |
More Info
|
CAY10789 |
A CysLT1 receptor antagonist (IC50 = 2.1 µM) |
10 mg |
35325-10 |
More Info
|
CAY10789 |
A CysLT1 receptor antagonist (IC50 = 2.1 µM) |
25 mg |
35325-25 |
More Info
|
CAY10789 |
A CysLT1 receptor antagonist (IC50 = 2.1 µM) |
5 mg |
35325-5 |
More Info
|
CAY10790 |
A CysLT1 receptor antagonist (IC50 = 2.8 µM) and GPBAR1 agonist; ind… |
1 mg |
35326-1 |
More Info
|
CAY10790 |
A CysLT1 receptor antagonist (IC50 = 2.8 µM) and GPBAR1 agonist; ind… |
10 mg |
35326-10 |
More Info
|
CAY10790 |
A CysLT1 receptor antagonist (IC50 = 2.8 µM) and GPBAR1 agonist; ind… |
25 mg |
35326-25 |
More Info
|
CAY10790 |
A CysLT1 receptor antagonist (IC50 = 2.8 µM) and GPBAR1 agonist; ind… |
5 mg |
35326-5 |
More Info
|
CAY10792 |
An anticancer agent; binds to Hsp90 and Cdc37 in cell-free assays; inhibit… |
1 mg |
37353-1 |
More Info
|
CAY10792 |
An anticancer agent; binds to Hsp90 and Cdc37 in cell-free assays; inhibit… |
10 mg |
37353-10 |
More Info
|
CAY10792 |
An anticancer agent; binds to Hsp90 and Cdc37 in cell-free assays; inhibit… |
5 mg |
37353-5 |
More Info
|
CAY10793 |
A quinazolinone-containing compound that is structurally similar to other… |
25 mg |
37436-25 |
More Info
|
CAY10793 |
A quinazolinone-containing compound that is structurally similar to other… |
5 mg |
37436-5 |
More Info
|
CAY10793 |
A quinazolinone-containing compound that is structurally similar to other… |
50 mg |
37436-50 |
More Info
|
CAY10794 |
An inhibitor of DGAT-1 (IC50 = 0.325 µM) |
10 mg |
37585-10 |
More Info
|